Is postoperative adjuvant chemoradiotherapy necessary for high-risk oropharyngeal squamous cell carcinoma?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
High-risk factors for recurrence of head and neck squamous cell carcinoma after surgical resection include involvement of ≥2 regional lymph nodes, extracapsular spread, and microscopic involvement of resected mucosal margins. Adjuvant chemoradiotherapy is thought to improve postoperative locoregional control and survival. In this paper, we evaluate the efficacy of adjuvant therapy for high-risk oropharyngeal squamous cell carcinoma (OPSCC) (i.e., with ≥2 lymph nodes, positive extracapsular spread, or positive margins).
This is a retrospective analysis of 45 high-risk OPSCC patients who underwent surgery without adjuvant therapy (n = 19), with radiotherapy (n = 17), or with chemoradiotherapy (n = 9).
The median follow-up period was 41.0 months. Radiotherapy patients showed a trend toward longer overall survival than patients without adjuvant therapy [hazard ratio (HR) = 0.32, p = 0.176]. However, overall survival for the chemoradiotherapy group seemed to be the same as that for the no adjuvant therapy group (HR = 0.79, p = 0.779). Multivariate analysis found that the relative risk of recurrence for patients without adjuvant therapy compared with any adjuvant therapy was 3.02 (p = 0.101). The relative recurrence risk in radiotherapy patients was 0.95 compared with that in chemoradiotherapy patients (p = 0.971). However, pathological T-stage was significantly associated with disease-free survival for high-risk OPSCC.
Although the current study uses data from a small retrospective sample of patients, our results suggest that the addition of chemotherapy to radiotherapy may not be necessary as an adjuvant therapy for all high-risk OPSCC. A novel prognostic factor, such as pathological T-stage, should be considered for selecting those patients with high-risk OPSCC who would benefit from adjuvant therapy.
- Marur, S, Forastiere, AA (2008) Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 83: pp. 489-501 CrossRef
- Zbaeren, P, Lehmann, W (1987) Frequency and sites of distant metastases in head and neck squamous cell carcinoma. Arch Otalaryngol Head Neck Surg 113: pp. 762-764 CrossRef
- Langendijk, JA, Ferlito, A, Takes, RP (2010) Postoperative strategies after primary surgery for squamous cell carcinoma of the head and neck. Oral Oncol 46: pp. 577-585 CrossRef
- Argiris, A, Karamouzis, MV, Raben, D (2008) Head and neck cancer. Lancet 371: pp. 1695-1709 CrossRef
- Mell, LK, Dignam, JJ, Salama, JK (2010) Predictors of competing mortality in advanced head and neck cancer. J Clin Oncol 28: pp. 15-20 CrossRef
- Cooper, JS, Pajak, TF, Forastiere, A (1998) Precisely defining high-risk operable head and neck tumors based on RTOG 85-03 and 88-24: targets for postoperative radiochemotherapy?. Head Neck 20: pp. 588-594 CrossRef
- Cooper JS, Pajak TF, Forastiere A et al for the Radiation Therapy Oncology Group 9501/Intergroup (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350:1937–1944
- Bernier J, Domenge C, Ozsahin M et al for the European Organization for Research and Treatment of Cancer Trial 22931 (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck. N Engl J Med 350:1945–1952
- Forastiere, AA, Goepfert, H, Maor, M (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349: pp. 2091-2098 CrossRef
- Garden, AS, Harris, J, Trotti, A (2008) Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys 71: pp. 1351-1355 CrossRef
- Machtay, M, Moughan, J, Trotti, A (2008) Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 26: pp. 3582-3589 CrossRef
- Licitra, L, Perrone, F, Bossi, P (2006) High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24: pp. 5630-5636 CrossRef
- Lewis, JS, Carpenter, DH, Thorstad, WL (2011) Extracapsular extension is a poor predictor of disease recurrence in surgically treated oropharyngeal squamous cell carcinoma. Mod Pathol 24: pp. 1413-1420 CrossRef
- Shiboski, CH, Schmidt, BL, Jordan, RC (2005) Tongue and tonsil carcinoma: increasing trends in the US population ages 20–44 years. Cancer 103: pp. 1843-1849 CrossRef
- Gillison, ML, Koch, WM, Shah, KV (1999) Human papillomavirus in head and neck squamous cell carcinoma: are some head and neck cancers a sexually transmitted disease?. Curr Opin Oncol 11: pp. 191-199 CrossRef
- Gillison, ML, Shah, KV (2001) Human papillomavirus-associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers. Curr Opin Oncol 13: pp. 183-188 CrossRef
- Boscolo-Rizzo, P, Gava, A, Baggio, V (2011) Matched survival analysis in patients with locoregionally advanced resectable oropharyngeal carcinoma: platinum-based induction and concurrent chemoradiotherapy versus primary surgical resection. Int J Radiat Oncol Biol Phys 80: pp. 154-160 CrossRef
- Ang, KK, Trotti, A, Brown, BW (2001) Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 51: pp. 571-578 CrossRef
- Peters, LJ, Goepfert, H, Ang, KK (1993) Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26: pp. 3-11 CrossRef
- Yao, M, Dornfeld, KJ, Buatti, JM (2005) Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma—the University of Iowa experience. Int J Radiat Oncol Biol Phys 63: pp. 410-421 CrossRef
- Withers, HR, Peters, LJ, Taylor, JM (1995) Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys 33: pp. 549-562 CrossRef
- Kao, J, Lavaf, A, Teng, MS (2008) Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol Biol Phys 71: pp. 362-370 CrossRef
- Tomita, N, Kodaira, T, Furutani, K (2010) Long-term follow-up and a detailed prognostic analysis of patients with oropharyngeal cancer treated with radiotherapy. J Cancer Res Clin Oncol 136: pp. 617-623 CrossRef
- Sher, DJ, Thotakura, V, Balboni, TA (2012) Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy. Ann Oncol 23: pp. 2391-2398 CrossRef
- El-Mofty, SK, Lu, DW (2003) Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol 27: pp. 1463-1470 CrossRef
- Ringstrom, E, Peters, E, Hasegawa, M (2002) Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. Clin Cancer Res 8: pp. 3187-3192
- Cohen, MA, Weinstein, GS, O’Malley, BW (2010) Transoral robotic surgery (TORS) and human papillomavirus (HPV) status: oncologic results. Head Neck Laryngoscope.
- Is postoperative adjuvant chemoradiotherapy necessary for high-risk oropharyngeal squamous cell carcinoma?
International Journal of Clinical Oncology
Volume 19, Issue 1 , pp 38-44
- Cover Date
- Print ISSN
- Online ISSN
- Springer Japan
- Additional Links
- Oropharyngeal cancer
- Adjuvant therapy
- High-risk patients
- Squamous cell carcinoma
- Industry Sectors
- Author Affiliations
- 1. Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi, Sunto-gun, Shizuoka, 411-8777, Japan
- 2. Division of Head and Neck Surgery, Shizuoka Cancer Center, Shizuoka, Japan
- 3. Division of Pathology, Shizuoka Cancer Center, Shizuoka, Japan
- 4. Division of Radiation Oncology, Shizuoka Cancer Center, Shizuoka, Japan
- 5. Division of Medical Oncology, Shizuoka Cancer Center, Shizuoka, Japan
- 6. Division of Plastic and Reconstructive Surgery, Shizuoka Cancer Center, Shizuoka, Japan